933,859 Shares in Tempus AI, Inc. (NASDAQ:TEM) Bought by Lingotto Investment Management LLP

Lingotto Investment Management LLP purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, Holdings Channel reports. The institutional investor purchased 933,859 shares of the company’s stock, valued at approximately $32,685,000. Tempus AI comprises 1.1% of Lingotto Investment Management LLP’s holdings, making the stock its 16th biggest holding.

A number of other hedge funds have also bought and sold shares of TEM. Massachusetts Financial Services Co. MA bought a new stake in shares of Tempus AI in the second quarter valued at $28,246,000. WINTON GROUP Ltd bought a new stake in shares of Tempus AI in the second quarter valued at $634,000. Allen Operations LLC bought a new stake in shares of Tempus AI in the second quarter valued at $3,831,000. Revolution Growth Management Company Inc. bought a new stake in shares of Tempus AI in the second quarter valued at $128,133,000. Finally, Federated Hermes Inc. bought a new stake in shares of Tempus AI in the second quarter valued at $19,886,000.

Tempus AI Stock Performance

NASDAQ:TEM opened at $49.23 on Wednesday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $77.00. The company’s fifty day moving average is $47.21.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. Research analysts forecast that Tempus AI, Inc. will post -6.51 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research reports. Needham & Company LLC restated a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Stifel Nicolaus initiated coverage on Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price on the stock. William Blair assumed coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an “outperform” rating on the stock. Morgan Stanley assumed coverage on Tempus AI in a research note on Tuesday, July 9th. They set an “overweight” rating and a $44.00 price objective on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $45.56.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.